Boston Partners Quidel Ortho Corp Transaction History

Boston Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$58.16 - $75.44 $364,663 - $473,008	-6,270 Reduced 4.17%	144,235 $10.6 Million
Q3 2023 Nov 07, 2023	SELL	$70.9 - $88.63 $310,825 - $388,553	-4,384 Reduced 2.83%	150,505 $11 Million
Q2 2023 Aug 10, 2023	SELL	$81.09 - $94.16 $516,218 - $599,422	-6,366 Reduced 3.95%	154,889 $12.8 Million
Q1 2023 May 09, 2023	BUY	$82.98 - $91.46 $1.09 Million - $1.2 Million	13,153 Added 8.88%	161,255 $14.4 Million
Q4 2022 Feb 07, 2023	SELL	$66.93 - $97.5 $290,877 - $423,735	-4,346 Reduced 2.85%	148,102 $12.7 Million
Q3 2022 Nov 09, 2022	SELL	$69.86 - $107.63 $9.88 Million - $15.2 Million	-141,386 Reduced 48.12%	152,448 $11.4 Million
Q2 2022 Aug 10, 2022	BUY	$89.06 - $117.64 $26.2 Million - $34.6 Million	293,834 New	293,834 $28.8 Million

286

67.6M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.91B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.